000 01246 a2200337 4500
005 20250516170536.0
264 0 _c20140930
008 201409s 0 0 eng d
022 _a1532-866X
024 7 _a10.1016/j.semarthrit.2013.07.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoman-Blas, Jorge A
245 0 0 _aAn OA phenotype may obtain major benefit from bone-acting agents.
_h[electronic resource]
260 _bSeminars in arthritis and rheumatism
_cFeb 2014
300 _a421-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aAnimals
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xpharmacology
650 0 4 _aBone Remodeling
_xdrug effects
650 0 4 _aCartilage, Articular
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aOsteoarthritis
_xdiagnostic imaging
650 0 4 _aRadiography
700 1 _aCastaƱeda, Santos
700 1 _aLargo, Raquel
700 1 _aLems, Willem F
700 1 _aHerrero-Beaumont, Gabriel
773 0 _tSeminars in arthritis and rheumatism
_gvol. 43
_gno. 4
_gp. 421-8
856 4 0 _uhttps://doi.org/10.1016/j.semarthrit.2013.07.012
_zAvailable from publisher's website
999 _c23071037
_d23071037